Key Financial Inc’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Key Financial Inc’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,500	Closed	-$9.56K	–	1366
2023 Q3	$9.56K	Hold	7,500	–	–	﹤0.01%	724
2023 Q2	$2.44K	Hold	7,500	–	–	﹤0.01%	1138
2023 Q1	$3.23K	Hold	7,500	–	–	﹤0.01%	883
2022 Q4	$5.49K	Hold	7,500	–	–	﹤0.01%	772
2022 Q3	$5K	Hold	7,500	–	–	﹤0.01%	813
2022 Q2	$9K	Buy	+7,500	New	+$9.55K	﹤0.01%	669

Key Financial Inc's ZYNE Position: Q4 2023 in Review

Key Financial Inc sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 7,500 shares — an estimated $9.56K sold.

Key Financial Inc first reported a position in ZYNE in Q2 2022 and held it in 6 quarters. The position peaked at $9.56K in Q3 2023. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

Key Financial Inc reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
Key Financial Inc sold 7,500 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $9.56K.
Key Financial Inc first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2022 and held it in 6 quarters.
Key Financial Inc's Zynerba Pharmaceuticals, Inc position peaked at $9.56K in Q3 2023.
0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Key Financial Inc's 13F filing for Q4 2023, filed 31 Jan 2024.